BrightSpring Health Services (NASDAQ:BTSG – Get Free Report) and Sera Prognostics (NASDAQ:SERA – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, valuation, institutional ownership, analyst recommendations, profitability, dividends and earnings.
Institutional and Insider Ownership
54.6% of Sera Prognostics shares are held by institutional investors. 3.4% of BrightSpring Health Services shares are held by insiders. Comparatively, 13.5% of Sera Prognostics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Analyst Recommendations
This is a summary of current ratings and recommmendations for BrightSpring Health Services and Sera Prognostics, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| BrightSpring Health Services | 0 | 1 | 9 | 0 | 2.90 |
| Sera Prognostics | 0 | 0 | 0 | 0 | 0.00 |
Risk & Volatility
BrightSpring Health Services has a beta of 2.39, suggesting that its share price is 139% more volatile than the S&P 500. Comparatively, Sera Prognostics has a beta of 0.97, suggesting that its share price is 3% less volatile than the S&P 500.
Profitability
This table compares BrightSpring Health Services and Sera Prognostics’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| BrightSpring Health Services | 0.55% | 9.29% | 2.64% |
| Sera Prognostics | -30,306.48% | -45.86% | -34.31% |
Valuation and Earnings
This table compares BrightSpring Health Services and Sera Prognostics”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| BrightSpring Health Services | $12.57 billion | 0.41 | -$18.06 million | $0.31 | 92.74 |
| Sera Prognostics | $108,000.00 | 1,091.82 | -$32.90 million | ($0.85) | -3.68 |
BrightSpring Health Services has higher revenue and earnings than Sera Prognostics. Sera Prognostics is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.
Summary
BrightSpring Health Services beats Sera Prognostics on 11 of the 14 factors compared between the two stocks.
About BrightSpring Health Services
BrightSpring Health Services, Inc. operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It serves patients through clinical providers and pharmacists. The company was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. BrightSpring Health Services, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky.
About Sera Prognostics
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preterm birth, preeclampsia, molecular time-to-birth, predictive analytics, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
Receive News & Ratings for BrightSpring Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BrightSpring Health Services and related companies with MarketBeat.com's FREE daily email newsletter.
